{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:28:05Z","timestamp":1773952085845,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T00:00:00Z","timestamp":1373328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00296-013-2799-8","type":"journal-article","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T10:26:30Z","timestamp":1373279190000},"page":"2827-2832","source":"Crossref","is-referenced-by-count":8,"title":["Clinical features and independent predictors in the further development of rheumatoid arthritis in undifferentiated arthritis"],"prefix":"10.1007","volume":"33","author":[{"given":"Dongying","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuqin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youjun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongping","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanshi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,9]]},"reference":[{"issue":"5 Suppl 35","key":"2799_CR1","first-page":"S12","volume":"22","author":"KN Verpoort","year":"2004","unstructured":"Verpoort KN et al (2004) Undifferentiated arthritis\u2014disease course assessed in several inception cohorts. Clin Exp Rheumatol 22(5 Suppl 35):S12\u2013S17","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"2799_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/rheumatology\/32.2.97","volume":"32","author":"EJ Tunn","year":"1993","unstructured":"Tunn EJ, Bacon PA (1993) Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheumatol 32(2):97\u2013103","journal-title":"Br J Rheumatol"},{"issue":"11","key":"2799_CR3","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/rheumatology\/35.11.1096","volume":"35","author":"BJ Harrison","year":"1996","unstructured":"Harrison BJ et al (1996) Natural remission in inflammatory polyarthritis: issues of definition and prediction. Br J Rheumatol 35(11):1096\u20131100","journal-title":"Br J Rheumatol"},{"issue":"1","key":"2799_CR4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2005.038471","volume":"65","author":"J Aken van","year":"2006","unstructured":"van Aken J et al (2006) Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study. Ann Rheum Dis 65(1):20\u201325","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2799_CR5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315\u2013324","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2799_CR6","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580\u20131588","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"2799_CR7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/0091270005277938","volume":"45","author":"T Doan","year":"2005","unstructured":"Doan T, Massarotti E (2005) Rheumatoid arthritis: an overview of new and emerging therapies. J Clin Pharmacol 45(7):751\u2013762","journal-title":"J Clin Pharmacol"},{"issue":"9602","key":"2799_CR8","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60784-3","volume":"370","author":"JS Smolen","year":"2007","unstructured":"Smolen JS et al (2007) New therapies for treatment of rheumatoid arthritis. Lancet 370(9602):1861\u20131874","journal-title":"Lancet"},{"issue":"10","key":"2799_CR9","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/rheumatology\/37.10.1084","volume":"37","author":"IE Horst-Bruinsma van der","year":"1998","unstructured":"van der Horst-Bruinsma IE et al (1998) Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care. Br J Rheumatol 37(10):1084\u20131088","journal-title":"Br J Rheumatol"},{"issue":"4","key":"2799_CR10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/ar1983","volume":"8","author":"AH Helm-van Mil van der","year":"2006","unstructured":"van der Helm-van Mil AH, Breedveld FC, Huizinga TW (2006) Aspects of early arthritis. Definition of disease states in early arthritis: remission versus minimal disease activity. Arthritis Res Ther 8(4):216","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2799_CR11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43(1):155\u2013163","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2799_CR12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1086\/342407","volume":"71","author":"D Jawaheer","year":"2002","unstructured":"Jawaheer D et al (2002) Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet 71(3):585\u2013594","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2799_CR13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/sarh.2002.32552","volume":"31","author":"MA Gonzalez-Gay","year":"2002","unstructured":"Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH (2002) Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 31(6):355\u2013360","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"2799_CR14","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/art.21739","volume":"54","author":"AH Helm-van Mil van der","year":"2006","unstructured":"van der Helm-van Mil AH et al (2006) The HLA\u2013DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 54(4):1117\u20131121","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2799_CR15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1755-7682-1-20","volume":"1","author":"NA Fathi","year":"2008","unstructured":"Fathi NA et al (2008) Diagnostic performance and predictive value of rheumatoid factor, anti-cyclic-citrullinated peptide antibodies and HLA\u2013DRB1 locus genes in rheumatoid arthritis. Int Arch Med 1(1):20","journal-title":"Int Arch Med"},{"issue":"9","key":"2799_CR16","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1136\/ard.2008.092676","volume":"68","author":"B Kuriya","year":"2009","unstructured":"Kuriya B et al (2009) Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis. Ann Rheum Dis 68(9):1482\u20131485","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"2799_CR17","first-page":"1393","volume":"6","author":"D Manivelavan","year":"2012","unstructured":"Manivelavan D, Vijayasamundeeswari CK (2012) Anti-cyclic citrullinated peptide antibody: an early diagnostic and prognostic biomarker of rheumatoid arthritis. J Clin Diagn Res 6(8):1393\u20131396","journal-title":"J Clin Diagn Res"},{"issue":"7","key":"2799_CR18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrrheum.2011.76","volume":"7","author":"WJ Venrooij van","year":"2012","unstructured":"van Venrooij WJ, van Beers JJ, Pruijn GJ (2012) Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol 7(7):391\u2013398","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"2799_CR19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3899\/jrheum.110967","volume":"39","author":"H Zeidler","year":"2012","unstructured":"Zeidler H (2012) The need to better classify and diagnose early and very early rheumatoid arthritis. J Rheumatol 39(2):212\u2013217","journal-title":"J Rheumatol"},{"issue":"11","key":"2799_CR20","first-page":"2258","volume":"29","author":"HR Schumacher","year":"2002","unstructured":"Schumacher HR (2002) Early arthritis clinics, much early arthritis is unclassified. J Rheumatol 29(11):2258\u20132260","journal-title":"J Rheumatol"},{"issue":"2","key":"2799_CR21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1515\/CCLM.2010.046","volume":"48","author":"Sang Mee Hwang","year":"2010","unstructured":"Hwang Sang Mee et al (2010) Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis. Clin Chem Lab Med 48(2):225\u2013230","journal-title":"Clin Chem Lab Med"},{"issue":"10","key":"2799_CR22","first-page":"450","volume":"49","author":"Sinyoung Kim","year":"2010","unstructured":"Kim Sinyoung et al (2010) Evaluation of three automated enzyme immunoassays for detection of anti-cyclic citrullinated peptide antibodies in qualitative and quantitative aspects. Rheumatology 49(10):450\u2013457","journal-title":"Rheumatology"},{"issue":"10","key":"2799_CR23","first-page":"2074","volume":"29","author":"AL Jansen","year":"2002","unstructured":"Jansen AL et al (2002) Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 29(10):2074\u20132076","journal-title":"J Rheumatol"},{"issue":"10","key":"2799_CR24","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantapaa-Dahlqvist","year":"2003","unstructured":"Rantapaa-Dahlqvist S et al (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48(10):2741\u20132749","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2799_CR25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00002281-200405000-00013","volume":"16","author":"Thomas D\u00f6rner","year":"2004","unstructured":"D\u00f6rner Thomas et al (2004) Rheumatoid factor revisited. Curr Opin Rheumatol 16(3):246\u2013253","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"2799_CR26","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2003.014233","volume":"63","author":"K Forslind","year":"2004","unstructured":"Forslind K et al (2004) Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 63(9):1090\u20131095","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"2799_CR27","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","volume":"65","author":"J Avouac","year":"2006","unstructured":"Avouac J, Gossec L, Dougados M (2006) Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 65(7):845\u2013851","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2799-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-013-2799-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2799-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T23:22:12Z","timestamp":1688340132000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-013-2799-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,9]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["2799"],"URL":"https:\/\/doi.org\/10.1007\/s00296-013-2799-8","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,9]]}}}